Aminoglycosides are broad-spectrum antibiotics used for treatment of serious bacterial infections, including the deadly tuberculosis and those accompanying AIDS, cystic fibrosis, and cancer. The emergence of pathogens resistant to these drugs represents a major threat to public health and underscores the need for new antimicrobial agents.
In Aim 1, we propose to utilize aminoglycoside-modifying enzymes of the aminoglycoside acetyltransferase (AAC) family in conjunction with a newly developed 6'-N-acylation protecting group-free chemical methodology (i) to generate in vitro libraries of new and more potent N-acylated aminoglycoside antibiotics, and (ii) to develop aminoglycoside probes that will serve as baits for identification of novel therapeutic protein targets/pathways for these antibiotics. Our chemoenzymatic and chemical strategies offer an effective solution to the following problems: (i) there are no existing general synthetic methodologies for the creation of N-acylated aminoglycosides, and (ii) there are no efficient methods to chemically modify specific amine groups on an aminoglycoside that contains a series of chemically identical amines. A few existing examples that use solely chemical syntheses are too demanding on research time and cost and are limited to very specific cases.
In Aim 2, we propose biochemical and structural studies of the mechanism of action and inhibition of a major determinant of aminoglycoside resistance in extensively drug-resistant strains of M. tuberculosis (XDR-TB). We expect this work to (i) advance the basic understanding of AG resistance of a variety of pathogenic bacteria, including M. tuberculosis, and (ii) provide a potential solution to overcome the aminoglycoside resistance problem in majority of XDR- TB. Relevance to public health: We expect that this work will contribute to the development of novel antibiotics with a potential to combat existing and newly emerging drug-resistant bacteria.
The proposed research is relevant to public health as an improved understanding of aminoglycoside- resistance enzymes is expected to lead to the discovery and development of new drugs and also in identifying drug targets. This research will enable us to better handle the problem of resistance of infectious bacteria to aminoglycoside antibiotics. The proposed research will have a major impact in two ways: (1) our novel chemical and chemoenzymatic methodologies for the rapid and facile regio- selective N-acylation of aminoglycosides will greatly reduce the cost and effort generally associated with such modifications, and (2) our study of the mechanism of action and inhibition of the major determinant of aminoglycosdie resistance in extensively drug-resistant M. tuberculosis will advance our understanding of drug resistance and also set a new paradigm of aminoglycoside acetyltransferase in the antibiotics field.
|Louzoun Zada, Sivan; Green, Keith D; Shrestha, Sanjib K et al. (2018) Derivatives of Ribosome-Inhibiting Antibiotic Chloramphenicol Inhibit the Biosynthesis of Bacterial Cell Wall. ACS Infect Dis 4:1121-1129|
|Holbrook, Selina Y L; Gentry, Matthew S; Tsodikov, Oleg V et al. (2018) Nucleoside triphosphate cosubstrates control the substrate profile and efficiency of aminoglycoside 3'-O-phosphotransferase type IIa. Medchemcomm 9:1332-1339|
|Holbrook, Selina Y L; Garneau-Tsodikova, Sylvie (2018) Evaluation of Aminoglycoside and Carbapenem Resistance in a Collection of Drug-Resistant Pseudomonas aeruginosa Clinical Isolates. Microb Drug Resist 24:1020-1030|
|Green, Keith D; Biswas, Tapan; Pang, Allan H et al. (2018) Acetylation by Eis and Deacetylation by Rv1151c of Mycobacterium tuberculosis HupB: Biochemical and Structural Insight. Biochemistry 57:781-790|
|Thamban Chandrika, Nishad; Shrestha, Sanjib K; Ranjan, Nihar et al. (2018) New Application of Neomycin B-Bisbenzimidazole Hybrids as Antifungal Agents. ACS Infect Dis 4:196-207|
|Thamban Chandrika, Nishad; Shrestha, Sanjib K; Ngo, Huy X et al. (2018) Novel fluconazole derivatives with promising antifungal activity. Bioorg Med Chem 26:573-580|
|Thamban Chandrika, Nishad; Shrestha, Sanjib K; Ngo, Huy X et al. (2018) Alkylated Piperazines and Piperazine-Azole Hybrids as Antifungal Agents. J Med Chem 61:158-173|
|Ngo, Huy X; Green, Keith D; Gajadeera, Chathurada S et al. (2018) Potent 1,2,4-Triazino[5,6 b]indole-3-thioether Inhibitors of the Kanamycin Resistance Enzyme Eis from Mycobacterium tuberculosis. ACS Infect Dis 4:1030-1040|
|Thamban Chandrika, Nishad; Garneau-Tsodikova, Sylvie (2018) Comprehensive review of chemical strategies for the preparation of new aminoglycosides and their biological activities. Chem Soc Rev 47:1189-1249|
|Fosso, Marina Y; Shrestha, Sanjib K; Thamban Chandrika, Nishad et al. (2018) Differential Effects of Linkers on the Activity of Amphiphilic Tobramycin Antifungals. Molecules 23:|
Showing the most recent 10 out of 52 publications